New paper outlines protocol for important TROG 20.01 CHEST-RT lung cancer trial

by Biotech Newsroom


TRIAL UPDATE: 15 July 2025

The TROG 20.01 CHEST-RT trial is set to add to the evidence about whether radiation therapy could be a safe and useful addition in the management of an aggressive form of lung cancer, as outlined in a newly published paper.

Congratulations to trial chairs Dr Eric Hau, from Westmead Hospital in NSW, and Dr Sagun Parakh, from Austin Hospital in Victoria, and the research team on the publication of the TROG 20.01 CHEST RT trial protocol paper in BMJ Open.

CHEST RT is investigating the addition of thoracic…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC